X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24) 24
humans (21) 21
female (18) 18
human papillomavirus (15) 15
vaccines (14) 14
adolescent (13) 13
cervical cancer (13) 13
adult (12) 12
papillomavirus infections (11) 11
papillomavirus infections - prevention & control (11) 11
womens health (11) 11
young adult (11) 11
analysis (10) 10
vaccination (10) 10
cancer (9) 9
infectious diseases (9) 9
papillomaviruses (9) 9
women (9) 9
young-women (9) 9
health aspects (8) 8
papillomavirus infections - epidemiology (8) 8
uterine cervical neoplasms - virology (8) 8
double-blind method (7) 7
infection (7) 7
papillomavirus infections - virology (7) 7
prevalence (7) 7
prevention (7) 7
uterine cervical neoplasms - prevention & control (7) 7
age (6) 6
australia - epidemiology (6) 6
infectious disease (6) 6
intraepithelial neoplasia (6) 6
male (6) 6
papillomavirus vaccines - administration & dosage (6) 6
papillomavirus vaccines - immunology (6) 6
particle vaccine (6) 6
research (6) 6
risk factors (6) 6
adjuvants, immunologic - administration & dosage (5) 5
age factors (5) 5
australia (5) 5
cervical intraepithelial neoplasia - prevention & control (5) 5
cross-sectional studies (5) 5
genotype (5) 5
hematology, oncology and palliative medicine (5) 5
human papillomavirus 16 - immunology (5) 5
human papillomavirus 18 - immunology (5) 5
immunization (5) 5
infections (5) 5
medicine (5) 5
medicine, general & internal (5) 5
middle aged (5) 5
oncology (5) 5
papillomaviridae - immunology (5) 5
papillomaviridae - isolation & purification (5) 5
research article (5) 5
sexually transmitted diseases (5) 5
treatment outcome (5) 5
cervical intraepithelial neoplasia - virology (4) 4
classification (4) 4
clinical trials (4) 4
epidemiology (4) 4
genetic aspects (4) 4
incidence (4) 4
papillomaviridae - classification (4) 4
public health (4) 4
risk (4) 4
united-states (4) 4
uterine cervical neoplasms - pathology (4) 4
warts (4) 4
broad-spectrum (3) 3
cervix (3) 3
chlamydia (3) 3
cross infection (3) 3
dna (3) 3
human papillomavirus 16 - genetics (3) 3
human papillomavirus 18 - genetics (3) 3
human-papillomavirus infection (3) 3
internal medicine (3) 3
lesions (3) 3
medical colleges (3) 3
medical research (3) 3
metaanalysis (3) 3
mortality (3) 3
multidisciplinary sciences (3) 3
natural-history (3) 3
nosocomial infections (3) 3
of-study analysis (3) 3
oncology, experimental (3) 3
papillomaviridae - genetics (3) 3
papillomavirus infections - diagnosis (3) 3
papillomavirus infections - pathology (3) 3
risk-factors (3) 3
science (3) 3
studies (3) 3
time factors (3) 3
united states (3) 3
uterine cervical neoplasms - diagnosis (3) 3
uterine cervical neoplasms - epidemiology (3) 3
abridged index medicus (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 10, pp. 1154 - 1168
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 5, pp. 487 - 500
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9961, pp. 2213 - 2227
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 775 - 786
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9574, pp. 1693 - 1702
Journal Article
Journal Article